IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $886,000 | -14.6% | 92,500 | -1.6% | 0.36% | -11.9% |
| Q2 2022 | $1,038,000 | -34.0% | 94,000 | -0.5% | 0.41% | -24.2% |
| Q1 2022 | $1,573,000 | -12.8% | 94,500 | 0.0% | 0.54% | +1.3% |
| Q4 2021 | $1,804,000 | -22.6% | 94,500 | 0.0% | 0.54% | -23.4% |
| Q3 2021 | $2,330,000 | -8.1% | 94,500 | -3.0% | 0.70% | -18.8% |
| Q2 2021 | $2,535,000 | +10.9% | 97,444 | +35.0% | 0.86% | +32.9% |
| Q1 2021 | $2,285,000 | -28.8% | 72,168 | +4.3% | 0.65% | -27.1% |
| Q4 2020 | $3,209,000 | +729.2% | 69,168 | +488.7% | 0.89% | +616.1% |
| Q3 2020 | $387,000 | +779.5% | 11,750 | +135.0% | 0.12% | +726.7% |
| Q4 2018 | $44,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |